News | October 25, 2021
Biocon reports a consolidated net profit of Rs. 138.3 crore in Q2FY22
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
Key takeaways of recent quarter & conference call highlights
Key takeaways of recent quarter & conference call highlights
The company reported 4% topline growth during the quarter driven by steady revenues in the Pharmaceuticals segment and robust growth in the Contract Research and Development Services (CRDS) segment
India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report
The company claims that its Empagliflozin tablets are the most affordable in India
The company operates four mid-sized hospitals with a total bed capacity of 556 in eastern India
This is a virtual event and the theme is `Transforming Healthcare beyond Covid’
Subscribe To Our Newsletter & Stay Updated
